ArticleMolecular therapy. Oncology2026

Mevalonate pathway activation in Ewing sarcoma reveals a 3D-specific synergy between statins and BCL-xL inhibition.

Branka Radic-Sarikas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.